Xiu Feng Li
Director/Board Member chez CHANGCHUN BCHT BIOTECHNOLOGY CO.
Fortune : 260 670 $ au 31/03/2024
Profil
Xiu Feng Li currently works at Changchun Baiyi Pharmaceutical Co., Ltd., as Vice Chairman from 2013, Jilin Huakang Pharmaceutical Co. Ltd., as Director from 2014, Changchun BCHT Biotechnology Co., as Director & Deputy General Manager from 2004, Changchun Chenguang Pharmaceutical Co. Ltd., as Director, Changchun BCHT Pharmaceuticals Co. Ltd., as Director from 2010, Jilin Maifeng Biological Pharmaceutical Co., Ltd., as Director, Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd., as Director, Changchun High-Tech Industry (Group) Co., Ltd., as Deputy General Manager from 2018, GeneScience Pharmaceuticals Co., Ltd., as Member-Supervisory Board from 2014, and Changchun Genescience Pharmaceuticals Co., Ltd., as Member-Supervisory Board.
Mr. Li received his graduate degree from Jilin University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/04/2023 | 15 675 ( 0,58% ) | 260 670 $ | 31/03/2024 |
Postes actifs de Xiu Feng Li
| Sociétés | Poste | Début |
|---|---|---|
| CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Corporate Officer/Principal | 26/06/2018 |
| CHANGCHUN BCHT BIOTECHNOLOGY CO. | Director/Board Member | 01/03/2004 |
| Changchun BCHT Pharmaceuticals Co. Ltd. | Director/Board Member | 20/08/2010 |
| Changchun Chenguang Pharmaceutical Co. Ltd. | Director/Board Member | 20/08/2010 |
| Jilin Maifeng Biological Pharmaceutical Co., Ltd. | Director/Board Member | 20/08/2010 |
| Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd. | Director/Board Member | 20/08/2010 |
Jilin Huakang Pharmaceutical Co. Ltd.
 Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dunhua, China. | Director/Board Member | 12/03/2014 |
GeneScience Pharmaceuticals Co., Ltd.
 GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Director/Board Member | 18/03/2014 |
Changchun Baiyi Pharmaceutical Co., Ltd.
 Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a private company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Director/Board Member | 01/08/2013 |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Xiu Feng Li
| Jilin University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Health Technology |
| CHANGCHUN BCHT BIOTECHNOLOGY CO. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Jilin Huakang Pharmaceutical Co. Ltd.
Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dunhua, China. | Health Technology |
GeneScience Pharmaceuticals Co., Ltd.
GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Health Technology |
| Changchun Chenguang Pharmaceutical Co. Ltd. | |
| Changchun BCHT Pharmaceuticals Co. Ltd. | |
| Jilin Maifeng Biological Pharmaceutical Co., Ltd. | |
| Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd. | |
Changchun Baiyi Pharmaceutical Co., Ltd.
Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a private company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Health Technology |
Changchun Genescience Pharmaceuticals Co., Ltd.
 Changchun Genescience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Genescience Pharmaceuticals Co., Ltd. is a private company that manufactures pharmaceutical products. Changchun Genescience Pharmaceuticals Co., Ltd. is based in Changchun, China. The Chinese company was founded in 1997. The CEO is Lei Jin. | Health Technology |
